학술논문
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension.
Document Type
Article
Author
Danese, Silvio; Panaccione, Remo; Abreu, Maria T; Rubin, David T; Ghosh, Subrata; Dignass, Axel; Afzali, Anita; Wolf, Douglas C; Chiorean, Michael V; Vermeire, Severine; Jain, Anjali; Charles, Lorna; Lawlor, Garrett; Osterman, Mark T; Wu, Hsiuanlin; Canavan, James B; Petersen, AnnKatrin; Colombel, Jean-Frederic; Regueiro, Miguel
Source
Journal of Crohn's & Colitis; Feb2024, Vol. 18 Issue 2, p264-274, 11p
Subject
Language
ISSN
18739946